MRE plus FIB-4 bests MAST, FAST to ‘rule in or rule out’ stage 2 fibrosis in NAFLD
LONDON — Magnetic resonance elastography in combination with the fibrosis-4 index was a better predictor of significant fibrosis in patients with nonalcoholic fatty liver disease vs. other noninvasive techniques, noted a presenter here.“NALFD patients with significant fibrosis — defined as those who have stage 2 or higher — are candidates for pharmacological treatments,” Rohit Loomba,…